April 2016 - OncoMasTR in the Irish Examiner
OncoMasTR assay for breast cancer featured in the Irish Examiner
Read an interview with OncoMark's Prof. William Gallagher's in the Irish Examiner here:
Informing Decisions,
Improving Care
Read an interview with OncoMark's Prof. William Gallagher's in the Irish Examiner here:
Prof. William Gallagher, OncoMark's Chief Scientific Officer, was interviewed for the Medical Independent in an article entitled 'Taking the fight to cancer' about progresses in cancer research in Ireland.
OncoMark are pleased to announce they have been awarded €2.7 million by the European Commission, for the commercial development of a new Diagnostic test for breast cancer patients. This award will fund the development and commercialisation of OncoMasTR, a novel prognostic assay for early stage breast cancer that will reduce the number of breast cancer patients receiving unnecessary chemotherapy.
We are pleased to announce the appointment of Mr Desmond O Leary to the position of Chief Executive Officer of OncoMark. Mr O Leary is an experienced executive with over 20 years in the diagnostic industry.
CEO of OncoMark, Dr Máirín Rafferty collects the award for Medical Laboratory of the Year at this year's Irish Laboratory Awards held in Dublin on Wednesday, 3rd December 2014.
Joe Barry, Managing Director of Lennox presents the award.